| PERIOD ENDING | 4-Oct-09 | 5-Jul-09 | 5-Apr-09 | 4-Jan-09 | | Total Revenue | 44,181 | 35,629 | 48,462 | 61,135 | | Cost of Revenue | 40,446 | 30,548 | 45,628 | 57,135 | | | Gross Profit | 3,735 | 5,081 | 2,834 | 4,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,760 | 2,745 | 3,857 | 3,414 | | Non Recurring |
-
| (191) | 974 | 704 | | Others |
-
|
-
|
-
| (613) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 975 | 2,527 | (1,997) | 495 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 975 | 2,527 | (1,997) | 495 | | Interest Expense | 473 | 538 | 327 | 672 | | Income Before Tax | 502 | 1,989 | (2,324) | (177) | | Income Tax Expense | 40 | (8) | 164 | (40) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 462 | 1,997 | (2,488) | (137) | | | Non-recurring Events | | Discontinued Operations | (297) | (5,447) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 165 | (3,450) | (2,488) | (137) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $165 | ($3,450) | ($2,488) | ($137) |
|
0.02% Nasdaq 
Income Statement
